A role for the heat shock protein-CD91 axis in the initiation of immune responses to tumors

Immunologic Research

Volumn 50, Issue 2-3, 2011, Pages 255-260

  Pawaria, Sudesh ^a   Messmer, Michelle Nicole ^a   Zhou, Yu Jerry ^a   Binder, Robert Julian ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD91; Concomitant immunity; Heat shock protein; Tumor immunity

Indexed keywords

CALRETICULIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; TUMOR REJECTION ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROSS LINKING; CROSS PRESENTATION; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; HEAT-SHOCK PROTEINS; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; NEOPLASMS; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 79961171291     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8221-2     Document Type: Article

References (55)

1. Ehrlich P. Collected studies on immunity. London, England: J. Wiley & Sons; 1906.
2. Bashford E, Murray J, Haaland M. Resistance and susceptibility to inoculated cancer. In: Bashford E, editor. Third scientific report on the investigations of the imperial cancer research fund. London, England: Taylor & Francis; 1908. p. 359-97.
3. RJ North DP Kirstein 1977 T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites J Exp Med 145 275 292 401860 10.1084/jem.145.2.275 1:STN:280:DyaE2s%2FpsFOmsg%3D%3D (Pubitemid 8032085)
4. G Klein HO Sjogren E Klein KE Hellstrom 1960 Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host Cancer Res. 20 1561 1572 13756652 1:STN:280:DyaF3c%2Fns1Crtg%3D%3D
5. LJ Old EA Boyse DA Clarke EA Carswell 1962 Antigenic properties of chemically induced tumors Ann NY Acad Sci 101 80 106 10.1111/j.1749-6632.1962. tb26446.x 1:CAS:528:DyaF3sXkt1Cjs7Y%3D
6. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 245 252 9521319 10.1038/32588 1:CAS:528:DyaK1cXitFWrsr8%3D (Pubitemid 28155090)
7. PK Srivastava AB DeLeo LJ Old 1986 Tumor rejection antigens of chemically induced sarcomas of inbred mice PNAS USA 83 3407 3411 3458189 10.1073/pnas.83.10.3407 1:CAS:528:DyaL28XktVCktr0%3D (Pubitemid 16043046)
8. H Udono PK Srivastava 1994 Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70 J Immunol 152 5398 5403 8189059 1:CAS:528:DyaK2cXksFGnsb0%3D (Pubitemid 24152988)
9. S Basu PK Srivastava 1999 Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity J Exp Med 189 797 802 10049943 10.1084/jem.189.5.797 1:CAS:528:DyaK1MXhsF2ju74%3D (Pubitemid 29189684)
10. XY Wang L Kazim EA Repasky JR Subjeck 2001 Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity J Immunol 166 490 497 11123328 1:CAS:528:DC%2BD3MXis1egtQ%3D%3D (Pubitemid 32038468)
11. PK Srivastava 1993 Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation Adv Cancer Res 62 153 177 8109317 10.1016/S0065-230X(08)60318-8 1:CAS:528: DyaK2cXktlamu7o%3D (Pubitemid 23361852)
12. Z Li PK Srivastava 1993 Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation EMBO J 12 3143 3151 8344253 1:CAS:528:DyaK3sXltlOjsb0%3D (Pubitemid 23232745)
13. P Peng A Menoret PK Srivastava 1997 Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography J Immunol Methods 204 13 21 9202705 10.1016/S0022-1759(97)00017-3 1:CAS:528: DyaK2sXisFKlsbg%3D (Pubitemid 27192307)
14. NE Blachere Z Li RY Chandawarkar, et al. 1997 Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity J Exp Med 186 1315 1322 9334371 10.1084/jem.186.8.1315 1:CAS:528:DyaK2sXmvVentr4%3D (Pubitemid 27469027)
15. H Udono T Yamano Y Kawabata M Ueda K Yui 2001 Recombinant fusions Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70 Int Immunol 13 1233 1242 11581168 10.1093/intimm/13.10.1233 1:CAS:528:DC%2BD3MXnvFShtLk%3D (Pubitemid 32994523)
16. B Liu D Ye X Song X Zhao L Yi J Song Z Zhang Q Zhao 2008 A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis Vaccine 26 1387 1396 18272260 10.1016/j.vaccine.2007.12.034 1:CAS:528:DC%2BD1cXitlemt7g%3D
17. M Navaratnam MS Deshpande MJ Hariharan DS Zatechka Jr S Srikumaran 2001 Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1 Vaccine 19 1425 1434 11163665 10.1016/S0264-410X(00)00381-9 1:CAS:528:DC%2BD3MXktlyqug%3D%3D (Pubitemid 32332727)
18. U Zügel AM Sponaas J Neckermann B Schoel SH Kaufmann 2001 gp96-peptide vaccination of mice against intracellular bacteria Infect Immun 69 4164 4167 11349093 10.1128/IAI.69.6.4164-4167.2001 (Pubitemid 32493345)
19. D Arnold C Wahl S Faath HG Rammensee H Schild 1997 Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96 J Exp Med 186 461 466 9236199 10.1084/jem.186.3.461 1:CAS:528:DyaK2sXlt1Snsbw%3D (Pubitemid 27332905)
20. F Belli A Testori L Rivoltini, et al. 2002 Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes J Clin Oncol 20 4169 4180 12377960 10.1200/JCO.2002.09.134 1:CAS:528:DC%2BD38XnsFyqsbg%3D (Pubitemid 35191019)
21. V Mazzaferro J Coppa MG Carrabba, et al. 2003 Vaccination with autologous tumor derived heat shock protein peptide complex Gp-96 (HSPPC-96) following curative resection of colorectal liver metastases Clin Cancer Res 9 3235 3245 12960108 1:CAS:528:DC%2BD3sXotFCksL4%3D
22. C Wood P Srivastava R Bukowski L Lacombe AI Gorelov S Gorelov P Mulders H Zielinski A Hoos F Teofilovici L Isakov R Flanigan R Figlin R Gupta B Escudier 2008 C-100-12 RCC Study Group: An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial Lancet 372 145 154 18602688 10.1016/S0140-6736(08)60697-2 1:CAS:528:DC%2BD1cXosVynurY%3D
23. A Testori J Richards E Whitman GB Mann J Lutzky L Camacho G Parmiani G Tosti JM Kirkwood A Hoos L Yuh R Gupta PK Srivastava 2008 C-100-21 Study Group: Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group J Clin Oncol 26 955 962 18281670 10.1200/JCO.2007.11.9941 1:CAS:528:DC%2BD1cXjtFelt7s%3D (Pubitemid 351398090)
24. H Udono DL Levey PK Srivastava 1994 Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo PNAS USA 91 3077 3081 7909157 10.1073/pnas.91.8.3077 1:CAS:528:DyaK2cXivFKls7o%3D (Pubitemid 24130178)
25. D Arnold-Schild D Hanau D Spehner, et al. 1999 Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells J Immunol 162 3757 3760 10201889 1:CAS:528: DyaK1MXitFGqsL0%3D (Pubitemid 29314749)
26. RJ Binder ML Harris A Menoret PK Srivastava 2000 Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells J Immunol 165 2582 2587 10946285 1:CAS:528: DC%2BD3cXmtFOrtLg%3D (Pubitemid 30660704)
27. RJ Binder DK Han PK Srivastava 2000 CD91: a receptor for heat shock protein gp96 Nat Immunol 1 151 155 11248808 10.1038/77835 1:CAS:528: DC%2BD3cXlsFOmurg%3D
28. S Basu RJ Binder T Ramalingam PK Srivastava 2001 CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin Immunity 14 303 313 11290339 10.1016/S1074-7613(01)00111-X 1:CAS:528:DC%2BD3MXis1ehurc%3D (Pubitemid 32289294)
29. RJ Binder PK Srivastava 2004 Essential role of CD91 in re-presentation of gp96-chaperoned peptides PNAS USA 101 6128 6133 15073331 10.1073/pnas. 0308180101 1:CAS:528:DC%2BD2cXjsFKnt78%3D (Pubitemid 38520539)
30. AA Tobian DH Canaday WH Boom CV Harding, et al. 2004 Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages J Immunol 172 5277 5286 15100266 1:CAS:528:DC%2BD2cXjt1Cksb8%3D (Pubitemid 38542025)
31. Y Delneste G Magistrelli J Gauchat, et al. 2002 Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation Immunity 17 353 362 12354387 10.1016/S1074-7613(02)00388-6 1:CAS:528:DC%2BD38XnsFGrsLo%3D (Pubitemid 35279555)
32. C Habich K Baumgart H Kolb V Burkart 2002 The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins J Immunol 168 569 576 11777948 1:CAS:528:DC%2BD38XksFWntA%3D%3D (Pubitemid 34049555)
33. PP Banerjee DS Vinay A Mathew, et al. 2002 Evidence that glycoprotein 96 (B2), a stress protein, functions as a Th2-specific costimulatory molecule J Immunol 169 3507 3518 12244140 1:CAS:528:DC%2BD38XnsFelsL0%3D
34. CA Ogden A deCathelineau PR Hoffmann, et al. 2001 C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells J Exp Med 194 781 795 11560994 10.1084/jem.194.6.781 1:CAS:528:DC%2BD3MXmvFGgsrc%3D (Pubitemid 32983014)
35. RW Vandivier CA Ogden VA Fadok, et al. 2002 Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex J Immunol 169 3978 3986 12244199 1:CAS:528:DC%2BD38XnsFelurw%3D
36. S Ling X Pi J Holoshitz 2007 The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin J Immunol 179 6359 6367 17947714 1:CAS:528:DC%2BD2sXhtFyksr3F
37. RJ Binder 2009 Hsp receptors: the cases of identity and mistaken identity Curr Opin Mol Ther 11 62 71 19169961 1:CAS:528:DC%2BC3cXnt1Kgtbk%3D
38. R Suto PK Srivastava 1995 A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides Science 269 1585 1588 7545313 10.1126/science.7545313 1:CAS:528:DyaK2MXotVOgtrk%3D
39. RJ Binder JB Kelly 3rd RE Vatner PK Srivastava 2007 Specific Immunogenicity of Heat Shock Protein gp96 Derives from Chaperoned Antigenic Peptides and Not from Contaminating Proteins J Immunol 179 7254 7261 18025167 1:CAS:528:DC%2BD2sXhtlajt77E
40. AD Doody JT Kovalchin MA Mihalyo AT Hagymasi CG Drake AJ Adler 2004 Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8(+) T cell effector function J Immunol 172 6087 6092 15128793 1:CAS:528:DC%2BD2cXjs1OjtbY%3D (Pubitemid 38621211)
41. D SenGupta PJ Norris TJ Suscovich, et al. 2004 Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II J Immunol 173 1987 1993 15265933 1:CAS:528:DC%2BD2cXlvVajtrk%3D (Pubitemid 38971635)
42. AA Tobian DH Canaday CV Harding 2004 Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells J Immunol 173 5130 5137 15470057 1:CAS:528:DC%2BD2cXotFCqu7Y%3D (Pubitemid 39387796)
43. T Matsutake T Sawamura PK Srivastava 2010 High efficiency CD91-and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules Cancer Immun 10 7 20672796
44. Pawaria S, Binder RJ. CD91 in encyclopedia of signaling molecules. New York: Springer; 2011. (in press).
45. RY Chandawarkar MS Wagh PK Srivastava 1999 The dual nature of specific immunological activity of tumor-derived gp96 preparations J Exp Med 189 1437 1442 10224283 10.1084/jem.189.9.1437 1:CAS:528:DyaK1MXivFGku7c%3D (Pubitemid 29227529)
46. S Basu RJ Binder R Suto KM Anderson PK Srivastava 2000 Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway Int Immunol 12 1539 1546 11058573 10.1093/intimm/12.11.1539 1:CAS:528: DC%2BD3cXosVWjtbY%3D
47. A De Maio 2011 Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: A form of communication during injury, infection, and cell damage: it is never known how far a controversial finding will go! Cell Stress Chaperones 16 235 249 20963644 10.1007/s12192-010- 0236-4 1:CAS:528:DC%2BC3MXkt12qsLc%3D
48. RJ Binder 2005 Srivastava PK: Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells Nat Immunol 6 593 599 15864309 10.1038/ni1201 1:CAS:528: DC%2BD2MXktlWitrc%3D (Pubitemid 41710730)
49. J Herz DK Strickland 2001 LRP: a multifunctional scavenger and signaling receptor J Clin Invest 108 779 784 11560943 1:CAS:528:DC%2BD3MXmvV2nt7c%3D (Pubitemid 32880284)
50. V Deretic 2011 Autophagy in immunity and cell-autonomous defense against intracellular microbes Immunol Rev 240 92 104 21349088 10.1111/j.1600-065X.2010. 00995.x 1:CAS:528:DC%2BC3MXktFehsbg%3D
51. KJ Ishii K Suzuki C Coban F Takeshita Y Itoh H Matoba LD Kohn 2001 Klinman DM Genomic DNA released by dying cells induces the maturation of APCs J Immunol 167 2602 2607 11509601 1:CAS:528:DC%2BD3MXmtlSjtrY%3D (Pubitemid 32768888)
52. Y Shi JE Evans KL Rock 2003 Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 516 521 14520412 10.1038/nature01991 1:CAS:528:DC%2BD3sXnslSis7g%3D (Pubitemid 37237047)
53. M Li GM Davey RM Sutherland C Kurts AM Lew C Hirst FR Carbone WR Heath 2001 Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo J Immunol 166 6099 6103 11342628 1:CAS:528: DC%2BD3MXjsFCqsb8%3D (Pubitemid 32440737)
54. S Jung D Unutmaz P Wong, et al. 2002 In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens Immunity 17 211 220 12196292 10.1016/S1074-7613(02)00365-5 1:CAS:528:DC%2BD38Xms12jsr8%3D (Pubitemid 35245963)
55. K Asano A Nabeyama Y Miyake CH Qiu A Kurita M Tomura O Kanagawa S Fujii M Tanaka 2011 CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens Immunity 34 85 95 21194983 10.1016/j.immuni.2010.12.011 1:CAS:528:DC%2BC3MXht1Wksro%3D